Don’t want to get too far ahead of ourselves but I wouldn’t be surprised if breakthrough designation is granted by the FDA on the back of these results. Potentially presenting us with revenue in a USD300M TAM as early as next year.
Not the news that the shorters would want to hear given they hold over 30M shares at very much an oversold level.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.38 |
Change
-0.280(6.01%) |
Mkt cap ! $1.628B | |||
| Open | High | Low | Value | Volume |
| $4.62 | $4.65 | $4.30 | $18.54M | 4.185M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 14980 | $4.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.39 | 2500 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |